HD Aronow, EJ Topol, MT Roe, PL Houghtaling … - The Lancet, 2001 - Elsevier Lipid-lowering therapy was associated with a smaller proportion of deaths at 30
days (17 [0·5%] vs 179 [1·0%], hazard ratio 0·44 [95% Cl 0·27–0·73],
p=0·001) and at 6 months (63 [1·7%] vs 605 [3·5%], 0·48 [0·37–0·63] ... Cited by 304 - Related articles - BL Direct - All 10 versions
AD Auerbach, L Goldman - Jama, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Recent studies ... Cited by 268 - Related articles - BL Direct - All 6 versions
AD Auerbach, L Goldman - Jama, 2002 - Am Med Assoc Recent studies suggest that -blockers administered perioperatively may reduce
the risk of adverse cardiac events and mortality in patients who have cardiac
risk factors and undergo major noncardiac surgery. The objective of this ... Cited by 164 - Related articles - BL Direct - All 3 versions
- ►annals.org SR Salpeter, TM Ormiston, EE Salpeter - Annals of internal medicine, 2002 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To assess the effect of cardioselective ß-blockers on ... Cited by 150 - Related articles - BL Direct - All 8 versions
MA Williams, JL Fleg, PA Ades, BR Chaitman, … - Circulation, 2002 - Am Heart Assoc Traditionally, components of secondary prevention programming (including
exercise; smoking cessation; management of dyslipidemia, hypertension, diabetes,
and weight; and interventions directed at depression, social isolation, ... Cited by 145 - Related articles - BL Direct - All 8 versions
- ►nih.gov [PDF] TA Stukel, FL Lucas, DE Wennberg - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context The health and ... Cited by 95 - Related articles - All 14 versions
DR Burwen, DH Galusha, JM Lewis, MR … - Archives of Internal Medicine, 2003 - Am Med Assoc Results Nationally, among patients without contraindications to therapy,
discharge -blocker prescription increased by 20.5 percentage points (50.3% to
70.7%); early administration of -blocker increased by 17.4 percentage ... Cited by 78 - Related articles - BL Direct - All 7 versions
SB Soumerai, TJ McLaughlin, D Ross-Degnan, … - Archives of Internal Medicine, 2002 - archinte.highwire.org Background National guidelines have encouraged increased use of thrombolytic
therapy for elderly patients with acute myocardial infarction (AMI). However,
evidence supporting thrombolytic therapy in patients 75 years and older is ... Cited by 74 - Related articles - BL Direct - All 6 versions
M Schmidt, PK Lindenauer, JL Fitzgerald, EM … - Archives of Internal Medicine, 2002 - Am Med Assoc Methods We conducted a retrospective cohort study, using administrative and
medical record review data, of all adult patients undergoing major noncardiac
surgery at Baystate Medical Center, Springfield, Mass, during a 1-month ... Cited by 77 - Related articles - BL Direct - All 6 versions
SR Salpeter, TM Ormiston, EE Salpeter, PJ … - Respiratory medicine, 2003 - Elsevier Beta-blocker therapy has a mortality benefit in patients with hypertension,
heart failure and coronary artery disease, as well as during the perioperative
period. These drugs have traditionally been considered contraindicated in ... Cited by 67 - Related articles - All 8 versions
